SUPER BUGS Act of 2026

Congress finds the following:

(1) Emerging infectious diseases, including antimicrobial-resistant pathogens, pose a significant threat to United States national security by—

(A) increasing the risk of outbreaks reaching the United States;

(B) disrupting critical infrastructure;

(C) undermining economic stability and public health; and

(D) undermining the readiness of the United States Armed Forces abroad.

(2) Strengthening international collaboration to develop, commercialize, and deploy qualified pandemic and epidemic products is essential to preventing, detecting, and containing infectious disease threats before they reach the borders of the United States.

(3) Enhancing partner countries’ public health capabilities and pandemic and epidemic response mechanisms directly contributes to United States homeland security by reducing the likelihood of global outbreaks affecting the United States.

(4) Coordinated strategies that leverage United States leadership, technology, and medical countermeasures, while ensuring equitable access for international partners, promote global resilience and reduce threats to United States citizens, infrastructure, and national interests.